Search
All Clinical Trials
A listing of 23116 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
3385 - 3396 of 23116
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
PTSD Treatment for Incarcerated Men and Women: WPP
Recruiting
Study examining the psychological response to group Cognitive Processing Therapy (CPT) in incarcerated men and women with Post-traumatic stress disorder (PTSD). The study will be conducted in male and female incarcerated populations and will include 2 groups of individuals for both CPT and waitlist control in both populations (140 participants total).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/29/2025
Locations: Psychiatric Institute and Clinic, Madison, Wisconsin
Conditions: PTSD
A Study of Zigakibart in Adults With IgA Nephropathy
Recruiting
Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/29/2025
Locations: University of Alabama at Birmingham: The Kirklin Clinic, Birmingham, Alabama +202 locations
Conditions: IgA Nephropathy, Immunoglobulin A Nephropathy
Evaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
Recruiting
The prevalence of daily cannabis use and Cannabis Use Disorder (CUD) has increased in the United States over the past two decades. Brief, computerized harm reduction interventions that target specific high-risk CUD populations could be an efficient approach to reducing CUD. Distress intolerance , which refers to the tendency to negatively appraise and escape aversive emotional states, is a risk factor associated with stress-related cannabis use motivation and CUD severity/chronicity. Thus, a bri... Read More
Gender:
ALL
Ages:
Between 18 years and 30 years
Trial Updated:
05/29/2025
Locations: Auburn University, Auburn, Alabama
Conditions: Cannabis Use Disorder
Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
Recruiting
This phase II trial tests how well venetoclax works in treating patients with hairy cell leukemia that has come back after a period of improvement (relapsed). Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/29/2025
Locations: UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida +11 locations
Conditions: Recurrent Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Variant
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
Recruiting
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of single doses of RN0361 in Adult healthy subjects and Adult Hypertriglyceridemic Subjects.
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
05/29/2025
Locations: Lifeline Primary Care/Avacare, Lilburn, Georgia +8 locations
Conditions: Hypertriglyceridemia, Familial Chylomicronemia Syndrome
Herbal Evaluation Of Artemisia Annua For Small Intestinal Bacterial Overgrowth
Recruiting
Small intestinal bacterial overgrowth (SIBO) can cause symptoms like bloating, stomach pain, and changes in bowel movements, significantly affecting quality of life. Many people with irritable bowel syndrome (IBS) also have SIBO, and there is growing recognition of how important it is to address this condition. Artemisia annua has shown potential in managing SIBO based on early reports and studies suggesting it can fight bacteria like \*E. coli\* and \*Klebsiella\*, which are linked to a type of... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/29/2025
Locations: Helfgott Research Institute - National University of Natural Medicine, Portland, Oregon
Conditions: Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
Recruiting
The goal of this clinical trial is to learn if a single knee injection of different doses (Dose A and Dose B) of an investigation product PCRX-201, following steroid pretreatment, is safe and tolerable in male of female patients 45 to 80 years old with osteoarthritis of the knee. It will also learn how the body reacts to the PCRX-201 injection and how effective the treatment is.
Researchers will compare Dose A and Dose B of PCRX-201 versus placebo from Week 1 through Week 52 to assess adverse e... Read More
Gender:
ALL
Ages:
Between 45 years and 80 years
Trial Updated:
05/29/2025
Locations: Alabama Clinical Therapeutics, LLC, Birmingham, Alabama +16 locations
Conditions: Osteoarthritis (OA) of the Knee
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
Recruiting
To develop and test liver cancer prevention educational material.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/29/2025
Locations: MD Anderson Cancer Center, Houston, Texas
Conditions: Liver Cancer
Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke
Recruiting
This study will examine the combination of myoelectric computer interface (MyoCI) training with targeted memory reactivation (TMR) in chronic stroke survivors. The study aims to determine whether this training-plus-sleep combination will generalize to improve arm motor function over an extended training protocol in stroke survivors.
Gender:
ALL
Ages:
Between 21 years and 100 years
Trial Updated:
05/29/2025
Locations: Northwestern University, Chicago, Illinois
Conditions: Stroke
Pimavanserin for Insomnia in Veterans With PTSD
Recruiting
This is a preliminary randomized, double-blind, placebo-controlled trial comparing pimavanserin 34mg at bedtime vs. placebo for the treatment of insomnia associated with post-traumatic stress disorder.
Gender:
ALL
Ages:
Between 18 years and 64 years
Trial Updated:
05/29/2025
Locations: Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas
Conditions: Post-traumatic Stress Disorder, Insomnia
SMARTer Weight Loss Management
Recruiting
The SMARTer trial will be a three-arm, randomized controlled non-inferiority trial that compares the optimized, adaptive SMARTer intervention, fixed DPP, and usual care assessment-only (Control). The trial will address whether a scalable, stepped-care intervention can stand up to gold-standard DPP by achieving comparable weight loss at a lower cost. Alongside evaluation of clinical non-inferiority, a comprehensive economic evaluation will inform relative affordability. Cost information is import... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/29/2025
Locations: Northwestern University, Chicago, Illinois
Conditions: Obesity
Smoking Cessation Program in the Construction Sector
Recruiting
The main objective of this study is to identify the optimal adaptive smoking cessation program for the construction sector in terms of effectiveness, cost-effectiveness, and potential implementation.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/29/2025
Locations: Don Soffer Clinical Research Center, Miami, Florida
Conditions: Smoking Cessation, Tobacco Use Cessation, Tobacco Smoking
3385 - 3396 of 23116